Home › Trial NCT05615129
Sequence and Time-of-day Infusion of immunoCHemotherapy Affect Response in Oesophageal Cancer in the NeOadjuvant Setting
- Trial IDNCT05615129
- StatusCompleted
- PhaseN/A
- Study typeObservational
- SponsorGuangdong Provincial People's Hospital
- Enrollment350
- Start date2021-10-01
- ConditionsEsophagus Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.